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Summary 
To evaluate the feasibility of temporary portal vein arterialization (PY A) in orthotopic partial 
liver transplantation (PL T), we performed 5 canine PL Ts with PY A assessing the changes in arterial 
ketone body ratio (AKER) as an index of hepatic energy status, and measuring portal pressure and 
flow. After anastomosis of hepatic vein, the graft liver was revascularized with arterial blood 
shunted from the external iliac artery to the hepatic side of the portal vein. By using this technique, 
both anhepatic period of the recipient and ischemic time, especially warm ischemic time , of the 
allograft were markedly shortened (31.0±4.5 min: Me且n± SEM). Four out of 5 recipients survived 
for at least 5 days (13 days in average). The AKER W旦srestored immed凶 elyafter PY A and show-
ed almost the same values as those at preclamping and after completion of anastomoses of both portal 
vein and hepatic artery. No significant difference in portal venous pressure was observed between 
during PY A and after vascular reconstruction. Portal blood flow during PY A was about one fourth 
of the total hepatic blood flow at preclamping. These results suggest that PY A can be used as an 
alternative procedure in PL T. 
Introduction 
Portal vein arterialization (PY A) shunti時 arterialblood to the intrahepatic portal vein (PY) has 
been used as a therapeutic modality to ameliorate the adverse metabolic eぽectsof portosystemic 
decompression l,2,1り Despiteits e侃cacydemonstrated by many experimental and clinical studies, 
this procedure was discountinued by reason for the severe liver damage caused by excessive arterial 
perfusion of the portal tree10・28）ー Onceassigned to obli,・ion, PYA has been retrieved due to 
microsurgical techniques that enable us to use a small artery for pressure-adapted low flow reperfu-
sion without causing histological disruption of the hepatocytes3・15l. 
Key words: Portal vein arterialization, Arterial ketone body ratio, Portal venous pressure, Hepatic blood flow. Liver 
transplantation. 
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Recently, Sheil et al. proposed the use of temporary PV A as a graft revascularization technique 
in orthotopic Ii ,・er transplantation 18). From the 、・iewpointof hepatic energy metabolism, we also 
found the beneficial effect of temporary PV-A as the revascularization technique after canine nor-
mothermic hepatic ischemia on hepatic ener肝 statususing arterial ketone body ratio (AKBR: 
acetoacetate/,3-hydroxybutyrate)25l. AKBR which reflects the hepatic mitochondrial redox state, 
has been shown to provide a rapid and accurate information with respect to graft viability5・14・2'i. 
¥' e have, therefore, applied this techinique to、arioushepatic surgical procedures, such as 
radical block resection for hilar bile duct cancer invading vessels. Differing from the whole liver 
replacement, however, the feasibility of PV A in PL T, which is characterized by reduced size of graft 
and by the outflow tract through hepatic、einanastomosis, has yet to be investigated. In the present 
study, we applied the temporary PV A technique to canine partial liver transplantation (PL T) in 
dogs, and ir日明tigatedits efficacy by measurement of AKBR as well as pressure and flow study. 
Materials and Methods 
Animals; Ten adult male beagles, weighing 9 10 kg, were su同ectedto 5 PL Ts. All animals were 
purchased from japan Clea Company, and were not allowed access to food other than water 24 hr prior 
to surgery. 
Anesthesia; The operation was performed under general intubational anesthesia and mechanical 
ventilation with 02-air mixture. Analgesia was maintained by initial intravenous administration of 
ketamine hydrochloride (5 mg/kg of body weight) and by supplemental dosages (1 mg/kg) as neede-
d. Muscular relaxation was obtained by intravenous administration of pancronium bromide (0.1 
mg/kg) as needed. The external jugular、・einwas can町n
of lactate Ringer's solution (30ロil/kg/l】r)and 5% glucose solution (8 mg/kg/hr). The carotid artery 
was cannulated for monitoring the systemic blood pressure (BP) and for sampling blood. Blood 
sugar (BS) and arterial oxygen tension (Pa02) were kept at the levels of BS> 150 mg/dl and Pa02 
> 150 mmHg to exclude the possible E仔ectsof fasting12l and hypox凶~1l on AKBR. Direct monitor-
ing of portal venous pressure (PVP) and sampling blood to measure the oxygen tension were done 
vほacatheter inserted into the gastroduodenal vein. Portal 、enousflow (PVF), hepatic arterial flow 
(HAF) and portal blood flow during PV A were measured with an ultrasonic range-gated pulsed Dop-
pler flowmeter (CRYSTAL BIOTECH, Holliston, MA, USA)6>. The flow probes were placed tight-
ly around the portal ,・ein (7-8 mm ind凶meter),hepatic artery (3 mm indiameter), and right exter-
nal iliac artery just porximal to the shunt tube ( 4-5 mm in diameter). 
Donor operation; Portal branches, hepatic arteries, and bile ducts to the right lateral, right medial 
lobes and caudate process were ligated and divided in the hepatic hilum. Hepatic parenchyma was 
transected along the interlobar plane between the right medial and left medial lobes. The graft liver, 
comprised of the left medial (Ll¥lL), left lateral lobes (LLL) and papillary process, was remo、’ed27)
and flushed in situ with 1 liter of cold lactated Ringer’s solution containing heparin (1000 unit/L) 
through the portal trunk. Vascular preparations were performed on a back table, keeping the graft 
cool by additional perfusion with 0.5 liter of the same lactated Ringer’s solution. The left hepatic 
、モinwas prepared for anastomosis by taking a small cuff from the wall of the IVC. 
Recipient preparation; Cιaval and portal decompression were performed with a centrifugal blood 
pump (Bio Medicus, Inc., Eden Parairie, Minnesota, USA) at a flow rate of more than 60 
PORTAL VEIN ARTERIALIZATION IN LIVER TRANSPLANTATION 385 
arterial blood 
Fig. 1 Schematic drawing of liver transplantation with portal vein arterialization technique. (HA) hepatic artery, 
(IVC) inferior vena cava; (LHV) left hepatic vein; (LLL) left lateral lobe; (LML) left med凶 lobe;(PV) portal 
vein 
ml/min/kg. The inferior vena cava was decompressed through a proximal left femoral vein, and the 
splanchnic bed was drained through a splenic vein. The spleen was resected. Withdrawn venous 
blood was returned through the left external jugular vein. Then, total hepatectomy was performed 
accoring to the method described by StarzP9l with special care as not to injure the IVC and closed al 
venous orifices draining into the IVC except for the orifice of left hepatic vein (LHV) which was left 
open and utilized for anastomosis to graft. Prior to removal of the recipient Ii、er,but before 
vascular interruption, a heparin-coated tube (anthron bypass tube, No. VSS-460, Toray Co. Ltd., 
Tokyo, Japan; outer diameter, 4 mm; inner diameter, 3 mm; length, 60 cm) was inserted into the 
recipient external iliac artery via the femoral artery. 
Transplantation; As shown in Fig. 1, the graft liver was put in orthotopically and the vascular 
reconstruction was performed as the following order: ( 1)Anastomosis between the LHV of donor 
and the LHV orifice of the recipient IVC. (2) Graft revascularization with PV A by insertion of the 
other end of the indwelling iliac arterial shunt tube to the hepatic side of PV (3) Anastomosis of the 
hepatic artery (HA). (4) Clamping of the iliac arterial shunt tube. (5) An昌stomosisof the PV us-
ing. (6) Removal of the veno-venous bypass. (7) Removal of the heparin-coate tube and repair of 
the right femoral artery using. (8) Anastomosis of the bile duct. 
Postoperative follow-up; Blood samples were taken for the measurement of AKBR throughout the 
operation, especially focusing the changes on the periods before, during, and after PV A. Arterial 
ketone bodies (acetoacetate and 13-hydroxybutyrate) were enzymatically by KETOREX Kit (Sanwa 
Chemical, Nagoya, Japan) and KET0-340, a semi-automatic spectrophotometer designed for the 
measurement of ketone bodies (!hara Electric Co., Kasugai, Japan)13・24l. 
Results are represented as mean±SEM. Statistical significance was determined by paired 
Student’s t est and p values less than 0.05 were considered to be significant. 
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Fig. 2 Changes in arterial ketone body ratio during liver transplantation, focusing on the period of portal vem 
arterialization. Values represent mean of 5 animals 
Results 
The weight of the graft liver was 156 ± 10 g which was estimated to be about half the total weight 
of the donor Ji、er(300 ± 15 g) and recipient Ii、er(295± 16 g). The total operation time was 310±25 
min, the anhepatic period was 85.0± 10.0 min, and the total ischemic time of the graft, from the 
clamping of hepatic circulation in the donor until revascularization of portal blood flow by PV A in 
the recipient, was 74.5士12.0min. The warm ischemic time of graft, from putting in the recipient’s 
abdominal ca,・ity until revascularization by arterial blood into the PV, was 31.0±4.5 min. The 
duration of PY A was 38.5士4.5min. 
AKER decreased significantly during the anhepatic phase compared with preclamping state and 
rapidl、restoredimmediately after PVA. The AKER during PV A showed almost the same values as 
those at pre clam ping of the donor, and AKER maintained higher le、・elsduring PV A plus HA inflow, 
and PV plus HA inflow (post-reconstruction) states. Moreo,・er, this value of PV A was significantly 
higher than that of anhepatic state and that of on！下 hepaticarterial inflow state (Fig. 2). 
Concerning portal vein pressure (PVP), total hepatic blood flow (THBF= PVF+ HAF) and ox-
ygen tension in portal blood, PVP during PVA was 21.5±1.5 cmH20 which was significantly 
(p<0.05) higher than that at preclamping (15.4±0.6 cmH20), and almost the same as the post-
reconstructive value (21.0± 1.0 cmH20). The preclamping PVF, HAF, and THBF were, 
27 .1 ±2.4 ml/kg/min, 4.5 ±0.8 ml/kg/min, and 31. 7 ±2.8 ml/kg/min, respectively. During PVA, 
arterial blood flow into the PY was 8.5 ±0. 7 ml/kg/min which was significantly lower than both the 
preclamping and post-reconstructive THBFs. Pa02 of portal blood during PVA was 165.1±12.0 
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Table 1. Changes in portal vein pressure, total hepatic blood flow and portal vein blood oxygen tension at 
preclamping and during arterialized and post-reconstructive periods 
preclamping arterialized post-reconstruct1ve 
portal vein pressure 15.4±0.6a) 21.5±1.5°) 21.0土1.0(cmH,0) 
山 ep叫 loodflow I阿 31.7士2.8 8.5±0. 7b) 24.7±2.2 0.9 (ml/kg/min) HAF 4.5±0.8 5.5± 
portal、emoxrf'~） tension 
(mm 92.5±11.0 165. l ± 12.01' 87.2士10.l 
PVF: portal venous flow, HAF: hepatic arterial flow 
a) mean土SEM
b) p<0.05, as compared with preclamping and/or post-reconstru山 vevalues 
mmHg which was significantly higher than the preclamping (92.5±11.0mmHg) and post-
reconstructive (87.2±10.1 mmHg) levels (Table. 1). During PLT procedure, sy町 micblood 
pressure was maintained between 110 and 180 mmHg. Four out of 5 recipients sur、l、吋forat least 
5 days (13.0±3.5 days; mean±SEM), and another animal died of outflow block on the first 
postoperative day. 
Discussion 
Temporary PY A technique in liver transplantation was first introduced to minimize both the 
ischemic time for the allograft and the anhepatic period for the recipient, as wel as to release the 
operators from the pressure of time constraints18l. It might wel be that the ultimate utility of this 
technique lies not in orthotopic liver transplantation but in PL T. In PL T for children, reconstruc-
tion of the hepatic vein and PY are the most di伍cultand time consuming parts of the whole pro-
cedure 27) that might exceed certain limits of the warm ischemic time. For success of liver transplan-
tation, the warm ischemic time must not exceed these limits and should be as short as possible. 
Shotening the warm ischemic time of the graft by using PY A is, therefore, reasonable for maintain-
ing the graft viability in good condition in PL T. 
The present report describes the significant decrease in both anhepatic period and ischemic time 
of the graft as compared with previous reports22・27l, which are almost the same in method except for 
PVA. Especially noteworthy is that the warm ischemic time was only 31 minutes, about a half of the 
limit of warm ischemia time in animals8・9) and humans'l 
Another advantage is the rapid recovery of the hepatic energy status of the graft. ¥Ve have 
shown that normalization of the mitochondrial redox state is essential for the reco、eryof the reduced 
graft metabolism and that AKER provides real-time information about these changes5・21l. And im-
mediate standing up and maintaining high level of AKER after revascularization of graft is an 
evidence of securing excellent viability of the graft. According to the AKER in this study, 
revascularization by PY A had the same beneficial effect on the restoration of the hepatic mitochon-
drial redox state as that of both PY and HA, which is in accordance with a previous report25l、 This
is further supported by the significantly high level of AKER during PY A compared with that of HA 
flow alone. 
Possible explanations for the ameliorative effects of PY A are summarized as follows: ( 1)the 
significantly high levels of Pa02 in portal blood during PY A contribute to the sufficient supply of ox 
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ygen needed in electron transport along the respiratory chain in the mitochondria. Furthermore, 
PV A is reported to improve liver regeneration after hepatectomy because of its high concentration of 
oxygen4l. (2) the significantly reduced warm ischemic time improves graft viability. It is reported 
that the negative correlation between the duration of warm ischemic period and the rate of AKBR 
recovery in PL T, and was uggested that graft viability depends on the warm ischemic time22l (3) 
the shunted arterial blood flow into the portal system maintains about one fourth of the preclamping 
THBF. According to a preliminary experiment using AKBR26l, the minimum blood flow needed to 
pres er.’t the viability of the liver during PV Awas only about 10% of the preclamping THBF. It is 
also reported that the safety limit of portal blood flow duri時 PVArt ex凶edbetween 10% and 25% 
of THBF by measuring the tissue adenine nucleotides of the liver17l. 
On the other hand, the main disadvantage of PV A is the risk of damage to the hepatocytes and 
portal vein branches caused by connect』ngthe high pressure arterial system to the intrahepatic portal 
vein1・2・10・11・28l. However, as long as the pressure and the inflow are maintained at or below the nor-
mal level, they have no adverse effect on hepatic function and architecture3・15・18.25) A significant in-
crease in PVP during PVA was observed as compared to preclamping value in this study. This in-
crease was considered not to be the e仔ectof PV A but due to the slightly stenotic LHV anastomosis or 
reduced liver mass, since no significant difference in PVP was observed between PVA and post-
reconstruction. This interpretation is supported by the previous report25l in which PVP during 
PV A showed almost the same value at preclamping in the absence of LHV anastomosis or liver mass 
reduction. The aplication of the PV A may bring more successful result in liver transplantation20). 
In conclusion, the PV A technique in PL T is an effective and safe method for maintaining the 
functional reserve of the graft liver. This technique could be used as an alternative procedure in 
PL T clinically, especially when obtaining a graft from a living donor. 
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イヌ 5頭に，一時的な門脈動脈化の手技を導入した れた．無肝期に低下した動脈血中ケト ン体比は門脈
部分肝移植を行い，動脈血中ケトン体比の変動．門脈 に動脈血流入開始後，速かに上昇し，iまぼ肝血流遮断
圧，肝血流量の変化を測定して，肝移植における門脈 前の値を示し，門脈，肝動脈両者の血行再建完成後も
動脈化手技導入の意義について検討した．肝静脈吻合 良好なその値を維持したー門脈動脈化中の門脈圧は，
｛去に，外腸骨動脈に挿入したチュープで門脈本幹に動 血行再建終了後と差はなかった．動脈化中の門脈血流
脈血で血行再開通を画り，この手技によって，レシピ 量は肝血行遮断前の全肝血流量のほぼ4分の lであっ
エントの無肝期と肝阻血時間，とくに温阻血時聞を平 た．門脈の動脈化は，肝移植施行に際し導入しうる，
均31分と短縮することがて、きた．レj ピエントの生存 有意義な手技と考えられる．
は， 5頭中4頭において最低5日間，平均13日が得ら
